Literature DB >> 14490114

Haemophilia in Sweden. III. Symptomatology, with special reference to differences between haemophilia A and B.

O RAMGREN.   

Abstract

Entities:  

Keywords:  HEMOPHILIA

Mesh：

Year:  1962        PMID： 14490114

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  6 in total

Review 1.  Hemophilia treatment in historical perspective: a review of medical and social developments.

Authors:  F R Rosendaal; C Smit; E Briët
Journal:  Ann Hematol       Date:  1991-02       Impact factor: 3.673

2.  Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial.

Authors:  Peter W Collins; Guy Young; Karin Knobe; Faraizah Abdul Karim; Pantep Angchaisuksiri; Claus Banner; Türkiz Gürsel; Johnny Mahlangu; Tadashi Matsushita; Eveline P Mauser-Bunschoten; Johannes Oldenburg; Christopher E Walsh; Claude Negrier
Journal:  Blood       Date:  2014-09-26       Impact factor: 22.113

3.  Target of prophylaxis in severe haemophilia: more than factor levels.

Authors:  Antonio Coppola; Massimo Franchini
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

4.  PTC deficiency with phalangeal and interphalangeal (arthritic) changes.

Authors:  J E Lewis; W I Sampson
Journal:  Calif Med       Date:  1972-03

5.  Joint haemorrhage in haemophilia: is full advantage taken of plasma therapy?

Authors:  A M Ali; R H Gandy; M I Britten; K M Dormandy
Journal:  Br Med J       Date:  1967-09-30

Review 6.  Primary prophylaxis in children with haemophilia.

Authors:  Antonio Coppola; Mirko Di Capua; Ciro De Simone
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.